• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Microbiol . The COVID-19 Diagnostic Dilemma: a Clinician's Perspective

tetano

Editor, Senior Moderator
J Clin Microbiol


. 2020 Jul 23;58(8):e01287-20.
doi: 10.1128/JCM.01287-20. Print 2020 Jul 23.
The COVID-19 Diagnostic Dilemma: a Clinician's Perspective


Ralph Rogers[SUP] 1 [/SUP], Thomas O'Brien[SUP] 2 [/SUP], Jad Aridi[SUP] 2 [/SUP], Curt G Beckwith[SUP] 2 [/SUP]



Affiliations

Abstract

In this commentary, we provide a broad overview of how the rapidly evolving coronavirus disease 2019 (COVID-19) diagnostic landscape has impacted clinical care during the COVID-19 pandemic. We review aspects of both molecular and serologic testing and discuss the logistical challenges faced with each. We also highlight the progress that has been made in the development and implementation of these assays as well as the need for ongoing improvement in diagnostic testing capabilities.

Keywords: COVID-19; SARS-CoV-2; molecular diagnostics; serologic testing.
 
Back
Top Bottom